Extrusion of Reactive Systems and Pharmaceutical Formulations
Hot Melt Extrusion For Amorphous Formulations
Transcript of Hot Melt Extrusion For Amorphous Formulations
Introduction
• Biopharmaceutical Classification System (BCS)
High Solubility Low Solubility
High permeability Class I Class II
Low permeability Class III Class IV
• High throughput screening is resulting in more complex API structures with an increase in Class II and Class IV APIs.
• About 40 % of all new APIs fail in development due to their poor solubility.
• There is a trend for recent drug candidates to be in Class II.
Introduction
• Process
– API, Thermoplastic Polymers
– Heating, Melting-Softening, Mixing
– Extrusion (Cylinders, Films)
– Cooling (On the Conveyor)
– Plasticizers, Surfactants, Antioxidants
• Advantages
– Continuous Process
– Absence of Solvents
– No Drying Step
– Amorphous Transformation
– Solid Solutions
– Interactions
Introduction
• Hot Melt Extrusion (Aspects)
– Processing• Miscibility• Temperature• Speed
– Characteristics• Solid Solution• Amorphous• Intermolecular Interactions
– Performance• Dissolution Rate• Supersaturation
– Stability• Characteristics• Performance
• Hot Melt Extrusion (Analytical Techniques)
– Solubility Parameters
– Thermal Analysis (DSC)
– Rheological Evaluation
– X-Ray Diffraction
– Polarized Light Microscopy
– IR Spectroscopy
– Dissolution Study
Processing (Materials)
• APIs (Model Drugs)
– Indomethacin (IND) (Tm = 162°C)
– Itraconazole (ITZ) (Tm = 165°C)
– Griseofulvin (GSF) (Tm = 220°C)
• Hydrophilic Polymers
– Eudragit EPO (Tg = 50°C)
– Eudragit L-100-55 (Tg = 110°C)
– Eudragit L-100 (Tg = 150°C)
– HPMCAS-LF (Tg = 120°C)
– HPMCAS-MF (Tg = 120°C)
– Pharmacoat 603 (Tg = 156°C)
– Kollidon VA-64 (Tg = 107°C)
Processing (Methods)
• Solubility Parameter Calculations
– ChemSW Software, Chemical Structures, Van Krevelen and Hoftyzer’s Group Contribution Method
• Preparation of Physical Mixtures
– Drug : Polymer (30:70, 50:50, 70:30) Ratios
– Mortar and Pestle, Amber Glass Bottles, Turbula Mixer
• Thermal Analysis
– 6-8 mg Sample, Heat-Cool-Heat Cycle, Heating Rate 10°C/min, Cooling Rate 50ºC/min, Melting Point, Glass Transition Temperature
• Rheological Evaluation
– Softening Temperatures, 20mm Steel Plate Geometry, Sample Thickness 1mm, Zero Rate Viscosity using Cross Model
• Hot Melt Extrusion
– Haake MiniLab Microcompounder, Manual Feeding, Temperature and Speed (Thermal and Rheological Evaluation), Extrudates – Milled, Screened, Stored in Desiccators
Processing (Solubility Parameters)
Prediction of immiscibility between ITZ and Eudragit EPO due to higher ∆δ
Processing (Thermal Analysis)
• Disobeying of Gordan-Taylor equation could be due to counter-ionic interaction between IND and Eudragit EPO
IND
ITZ
GSF
Processing (Rheological Evaluation)
IND (100 rpm), ITZ (150 rpm), and GSF (200 rpm) at their softening temperatures
Comparison of softening temperatures of PMs Comparison of η0 at same softening temperatures
Processing (Rheological Evaluation)
η0 was dependent on the concentration and state of the drug in the PMs at the softening temperatures
IND GSF
ITZITZ
Processing (Summary)
• Solubility Parameters
– Prediction of immiscibility between ITZ and Eudragit EPO
• Thermal Analysis
– Confirmation of immiscibility between ITZ and Eudragit EPO
– Prediction of physical state of the extrudates
– Exceptions to Gordon Taylor equation – stronger counter-ionic interactions (IND : Eudragit EPO)
• Rheological Evaluation
– Estimation of processing conditions for HME – softening temperatures and zero rate viscosity
• Hot Melt Extrusion
– Transparent glassy HMEs (Solid Solutions)
Performance (Materials)
• APIs (Model Drugs)
– Indomethacin (IND) (Weak Acid)
– Itraconazole (ITZ) (Weak Base)
– Griseofulvin (GSF) (Neutral)
• Hydrophilic Polymers
– Eudragit EPO (Cationic)
– Eudragit L-100-55 (Anionic)
– Eudragit L-100 (Anionic)
– HPMCAS-LF (Anionic)
– HPMCAS-MF (Anionic)
– Pharmacoat 603 (Non-ionic)
– Kollidon VA-64 (Non-ionic)
Performance (Materials)
IND ITZ
Prediction of dissolution improvement in unfavorable pH conditions due to counter-ionic interactions
0
20
40
60
80
100
0 2 4 6 8 10 12 14
% Io
niz
ed
pH
pH Dependent Ionization
Indomethacin IND pKa
0
20
40
60
80
100
0 2 4 6 8 10 12 14
% Io
niz
ed
pH
pH Dependent Ionization
Itraconazole ITZ pKa
Performance (Methods)
• Powder X-Ray Diffraction (PXRD)
– PMs, and Milled HMEs, Cu K α Radiation, Angular Range of 1 < 2θ < 40°, Step Width 0.02°, Scan Rate 1°/ per minute
• Polarized Light Microscopy (PLM)
– Light Intensity 5.0, Magnification 10X
– PMs & Milled HMEs in Mineral Oil, and Milled HMEs in Dissolution Medium
• FT-IR Spectroscopy
– Smart Orbit Accessory, Nicolet Nexus FT-IR, Omnic Software
– PMs of crystalline and amorphous APIs with the polymers, Milled HMEs
• Dissolution Study
– PMs and Milled HMEs
– USP Dissolution Apparatus II, 0.1N HCl (SGF), Phosphate Buffer pH 6.8 (SIF), 37°C, 50rpm
– IND (Tablets, 320nm), ITZ (Powder, 263nm), and GSF (Powder, 293nm)
Performance (FT-IR Spectroscopy) (GSF)
• Intermolecular interactions between the drugs and the polymers during HME
• Not possible to distinguish the stronger counter-ionic interactions
Performance (Dissolution Study – IND)
Only counter-ionic polymer improved the dissolution of IND in SGF
Performance (Dissolution Study – ITZ)
Only counter-ionic polymers improved the dissolution of ITZ in SIF
Performance (Dissolution Study)
Dissolution of GSF was improved in both SGF and SIF using all the polymers
Performance (Summary)
• PXRD Analysis
– Amorphous transformation due to HME
– Amorphous transformation – Independent of API concentration
• PLM
– No surface crystallization of APIs on the HMEs due to dissolution medium
– No reduction in dissolution due to surface crystallization
• FTIR Spectroscopy
– Intermolecular interactions between the drugs and the polymers during HME
– Not possible to distinguish the stronger counter-ionic interactions
• Dissolution Study
– Dissolution of all the drugs was improved using HME technology
– Improvement was dependent on pH dependent ionization and drug-polymer interactions for IND and ITZ than merely amorphous transformation
– Improvement was dependent on both amorphous transformation and drug-polymer interactions for GSF
Stability (Materials)
• Formulations
– IND : Eudragit EPO (30:70)
– IND : Kollidon VA-64 (30:70)
– ITZ : HPMCAS-LF (30:70)
– ITZ : Kollidon VA-64 (30:70)
Stability (Methods)
• Hot Melt Extrusion
– Leistritz Hot Melt Extruder Micro-18 Model, Four Barrels, Conveying Elements, Co-Rotating Twin-Screws, 400g PM, 15g/min, Extrudates – Milled, Screened, Stored in Desiccator at 5°C
• Stability Chambers
– Saturated Salt Solutions, Closed Porous Plastic Containers, Analysis – 1, 3, 6, 9, 12 Weeks
• Moisture Analysis
– Los on Drying (LOD), Pre-weighed Aluminium Pans, % Weight Loss, % Moisture Content
• Thermal Analysis
– 6-8 mg Sample, Heat-Cool-Heat Cycle, Heating Rate 10°C/min, Cooling Rate 50ºC/min, Melting Point, Glass Transition Temperature
• Powder X-Ray Diffraction (PXRD)
– Milled HMEs, Cu K α Radiation, Angular Range of 1 < 2θ < 40°, Step Width 0.02°, Scan Rate 1°/ per minute
• Dissolution Study
– USP Dissolution Apparatus II, 0.1N HCl (SGF), Phosphate Buffer pH 6.8 (SIF), 37°C, 50rpm
– IND (265nm), and ITZ (263nm)
Stability (Hot Melt Extrudates)
• Four barrel system of Leistritz extruder with all the conveying elements of co-rotating twin screws simulated well with the design of Mini-Lab MicroCompounder
• Transparent glassy HMEs could be produced using temperatures and speeds estimated in part I
Stability (Moisture Analysis)
Moisture content was increased with temperature and humidity over time
(a) IND : Eudragit EPO
0
2
4
6
8
10
1 W
eek 3 6 9
12
1 W
eek 3 6 9
12
1 W
eek 3 6 9
12
1 W
eek 3 6 9
12
1 W
eek 3 6 9
12
1 W
eek 3 6 9
12
1 W
eek 3 6 9
12
1 W
eek 3 6 9
12
1 W
eek 3 6 9
12
34% RH 76% RH 96% RH 33% RH 75% RH 97% RH 31% RH 74% RH 96% RH
Initial 5°C 25°C 50°C
Stability Conditions
Mo
istu
re C
on
ten
t (%
w/w
)
Stability (Moisture Analysis)
Moisture content was increased with temperature and humidity over time
(b) IND : Kollidon VA-64
0
2
4
6
8
10
1 W
ee
k 3 6 9
12
1 W
ee
k 3 6 9
12
1 W
ee
k 3 6 9
12
1 W
ee
k 3 6 9
12
1 W
ee
k 3 6 9
12
1 W
ee
k 3 6 9
12
1 W
ee
k 3 6 9
12
1 W
ee
k 3 6 9
12
1 W
ee
k 3 6 9
12
34% RH 76% RH 96% RH 33% RH 75% RH 97% RH 31% RH 74% RH 96% RH
Initial 5°C 25°C 50°C
Stability Conditions
Mo
istu
re C
on
ten
t (%
w/w
)
Stability (Moisture Analysis)
Moisture content was increased with temperature and humidity over time
(a) ITZ : HPMCAS-LF
0
2
4
6
1 W
eek 3 6 9
12
1 W
eek 3 6 9
12
1 W
eek 3 6 9
12
1 W
eek 3 6 9
12
1 W
eek 3 6 9
12
1 W
eek 3 6 9
12
1 W
eek 3 6 9
12
1 W
eek 3 6 9
12
1 W
eek 3 6 9
12
34% RH 76% RH 96% RH 33% RH 75% RH 97% RH 31% RH 74% RH 96% RH
Initial 5°C 25°C 50°C
Stability Conditions
Mo
istu
re C
on
ten
t (%
w/w
)
Stability (Moisture Analysis)
Prediction of instability of ITZ : Kollidon VA-64 HMEs due to higher moisture content
(b) ITZ : Kollidon VA-64
0
3
6
9
12
15
1 W
eek 3 6 9
12
1 W
eek 3 6 9
12
1 W
eek 3 6 9
12
1 W
eek 3 6 9
12
1 W
eek 3 6 9
12
1 W
eek 3 6 9
12
1 W
eek 3 6 9
12
1 W
eek 3 6 9
12
1 W
eek 3 6 9
12
34% RH 76% RH 96% RH 33% RH 75% RH 97% RH 31% RH 74% RH 96% RH
Initial 5°C 25°C 50°C
Stability Conditions
Mo
istu
re C
on
ten
t (%
w/w
)
Stability (Thermal Analysis)(a) IND:Eudragit EPO
0
20
40
60
80
100
34%
76%
96%
33%
75%
97%
31%
74%
96%
34%
76%
96%
33%
75%
97%
31%
74%
96%
34%
76%
96%
33%
75%
97%
31%
74%
96%
34%
76%
96%
33%
75%
97%
31%
74%
96%
34%
76%
96%
33%
75%
97%
31%
74%
96%
5°C 25°C 50°C 5°C 25°C 50°C 5°C 25°C 50°C 5°C 25°C 50°C 5°C 25°C 50°C
Initial 1 Week 3 Weeks 6 Weeks 9 Weeks 12 Weeks
Stability Conditions
Gla
ss T
ran
sit
ion
Te
mp
era
ture
(b) IND:Kollidon VA-64
0
20
40
60
80
100
34%
76%
96%
33%
75%
97%
31%
74%
96%
34%
76%
96%
33%
75%
97%
31%
74%
96%
34%
76%
96%
33%
75%
97%
31%
74%
96%
34%
76%
96%
33%
75%
97%
31%
74%
96%
34%
76%
96%
33%
75%
97%
31%
74%
96%
5°C 25°C 50°C 5°C 25°C 50°C 5°C 25°C 50°C 5°C 25°C 50°C 5°C 25°C 50°C
Initial 1 Week 3 Weeks 6 Weeks 9 Weeks 12 Weeks
Stability Conditions
Gla
ss
Tra
nsit
ion
Te
mp
era
ture
(a) ITZ:HPMCAS-LF
0
20
40
60
80
100
34%
76%
96%
33%
75%
97%
31%
74%
96%
34%
76%
96%
33%
75%
97%
31%
74%
96%
34%
76%
96%
33%
75%
97%
31%
74%
96%
34%
76%
96%
33%
75%
97%
31%
74%
96%
34%
76%
96%
33%
75%
97%
31%
74%
96%
5°C 25°C 50°C 5°C 25°C 50°C 5°C 25°C 50°C 5°C 25°C 50°C 5°C 25°C 50°C
Initial 1 Week 3 Weeks 6 Weeks 9 Weeks 12 Weeks
Stability Conditions
Gla
ss T
ran
sit
ion
Te
mp
era
ture
(b) ITZ:Kollidon VA-64
0
20
40
60
80
100
34%
76%
96%
33%
75%
97%
31%
74%
96%
34%
76%
96%
33%
75%
97%
31%
74%
96%
34%
76%
96%
33%
75%
97%
31%
74%
96%
34%
76%
96%
33%
75%
97%
31%
74%
96%
34%
76%
96%
33%
75%
97%
31%
74%
96%
5°C 25°C 50°C 5°C 25°C 50°C 5°C 25°C 50°C 5°C 25°C 50°C 5°C 25°C 50°C
Initial 1 Week 3 Weeks 6 Weeks 9 Weeks 12 Weeks
Stability Conditions
Gla
ss T
ran
sit
ion
Te
mp
era
ture
Prediction of instability of IND : Eudragit EPO due to lower Tg
Stability (Thermal Analysis)
Prediction of ITZ crystallization at 50°C, 74%RH and 96%RH after 6 weeks
Stability (Thermal Analysis)
Prediction of ITZ crystallization at 50°C, 96%RH due to phase separation
Stability (Powder X-Ray Diffraction)
Prediction of reduction in ITZ dissolution for stability samples with crystallization
Stability (Dissolution Study – IND : Eudragit EPO)
Possible increase in counter-ionic interactions with the increase in temperature and humidity over time
Stability (Summary)
• Hot Melt Extrusion
– Possible to predict feasibility of HME production at large scale by simulating designs of the extruders
• Moisture Analysis
– Moisture content increased with time, temperature, and humidity
– The hygroscopicity of vinyl polymer was higher than that of methacrylic and cellulosic polymers
• Thermal Analysis
– Amorphous ITZ was physically unstable at higher temperatures and humidity levels
– The crystallization and phase separation of ITZ could be determined using DSC
• Powder X-Ray Diffraction
– Crystallization of ITZ could be confirmed
• Dissolution Study
– Dissolution of ITZ was reduced for stability samples with crystallization
– Dissolution of IND was reduced for stability samples with chemical degradation
– Supersaturation of ITZ and IND was improved over stability period for HMEs with polymers counter-ionic to these drugs
Exciting Discovery
• Drug-Polymer interactions play an important role in
– Processing HME product
– Improving dissolution rate
– Enhancing supersaturation levels
• The supersaturation of ionic drugs was improved in unfavorable pH conditions possibly due to improvement in counter-ionic interactions with the polymers
• These counter-ionic interactions could have been increased due to water assisted charge transfer
• The controlled use of temperature and moisture could be beneficial to improve the intermolecular interactions to sustain the supersaturation levels